Jyong Biotech (MENS) Competitors $19.12 +0.06 (+0.31%) As of 08/1/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock MENS vs. CYTK, ZLAB, ADMA, ABVX, RNA, MTSR, AKRO, ACLX, ACAD, and VKTXShould you be buying Jyong Biotech stock or one of its competitors? The main competitors of Jyong Biotech include Cytokinetics (CYTK), Zai Lab (ZLAB), ADMA Biologics (ADMA), Abivax (ABVX), Avidity Biosciences (RNA), Metsera (MTSR), Akero Therapeutics (AKRO), Arcellx (ACLX), ACADIA Pharmaceuticals (ACAD), and Viking Therapeutics (VKTX). These companies are all part of the "pharmaceutical products" industry. Jyong Biotech vs. Its Competitors Cytokinetics Zai Lab ADMA Biologics Abivax Avidity Biosciences Metsera Akero Therapeutics Arcellx ACADIA Pharmaceuticals Viking Therapeutics Cytokinetics (NASDAQ:CYTK) and Jyong Biotech (NASDAQ:MENS) are both pharmaceutical products companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, media sentiment, earnings, dividends and profitability. Is CYTK or MENS more profitable? Jyong Biotech has a net margin of 0.00% compared to Cytokinetics' net margin of -3,201.47%. Company Net Margins Return on Equity Return on Assets Cytokinetics-3,201.47% N/A -43.75% Jyong Biotech N/A N/A N/A Do analysts recommend CYTK or MENS? Cytokinetics presently has a consensus target price of $70.92, suggesting a potential upside of 93.30%. Given Cytokinetics' stronger consensus rating and higher probable upside, research analysts clearly believe Cytokinetics is more favorable than Jyong Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cytokinetics 0 Sell rating(s) 4 Hold rating(s) 10 Buy rating(s) 2 Strong Buy rating(s) 2.88Jyong Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor CYTK or MENS? In the previous week, Cytokinetics had 12 more articles in the media than Jyong Biotech. MarketBeat recorded 12 mentions for Cytokinetics and 0 mentions for Jyong Biotech. Cytokinetics' average media sentiment score of 0.69 beat Jyong Biotech's score of 0.00 indicating that Cytokinetics is being referred to more favorably in the media. Company Overall Sentiment Cytokinetics Positive Jyong Biotech Neutral Which has better valuation & earnings, CYTK or MENS? Jyong Biotech has lower revenue, but higher earnings than Cytokinetics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCytokinetics$18.47M237.24-$589.53M-$5.29-6.94Jyong BiotechN/AN/AN/AN/AN/A SummaryCytokinetics beats Jyong Biotech on 7 of the 9 factors compared between the two stocks. Get Jyong Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for MENS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MENS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MENS vs. The Competition Export to ExcelMetricJyong BiotechPharmaceutical Preparations IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$1.45B$835.93M$2.54B$9.36BDividend YieldN/A4.84%2.62%4.14%P/E RatioN/A1.3422.0723.77Price / SalesN/A25.6979.0797.24Price / CashN/A19.5626.9427.20Price / BookN/A6.6838.225.61Net IncomeN/A-$3.67M$28.61M$265.26M7 Day Performance32.04%-5.54%-2.21%-4.34%1 Month Performance140.81%-1.78%-1.42%4.11%1 Year PerformanceN/A15.62%26.87%17.92% Jyong Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MENSJyong BiotechN/A$19.12+0.3%N/AN/A$1.45BN/A0.0031CYTKCytokinetics4.082 of 5 stars$36.63-1.5%$70.92+93.6%-35.8%$4.37B$18.47M-6.92250News CoverageUpcoming EarningsAnalyst ForecastInsider TradeZLABZai Lab2.4081 of 5 stars$38.69+4.1%$54.28+40.3%+102.2%$4.30B$418.33M-15.541,869News CoveragePositive NewsUpcoming EarningsShort Interest ↑Gap UpADMAADMA Biologics4.2798 of 5 stars$18.00-0.1%$27.67+53.7%+65.4%$4.30B$459.38M21.18530News CoverageUpcoming EarningsABVXAbivax3.5818 of 5 stars$66.57+0.1%$80.00+20.2%+501.0%$4.23BN/A0.0061News CoverageAnalyst ForecastGap DownHigh Trading VolumeRNAAvidity Biosciences2.7967 of 5 stars$34.56-4.7%$66.35+92.0%-13.0%$4.17B$10.90M-11.52190News CoverageUpcoming EarningsHigh Trading VolumeMTSRMetseraN/A$39.43-2.6%$55.00+39.5%N/A$4.14BN/A0.0081Earnings ReportLockup ExpirationGap DownAKROAkero Therapeutics3.9716 of 5 stars$49.24-2.6%$82.50+67.5%+92.2%$3.93BN/A-25.2530Positive NewsUpcoming EarningsACLXArcellx2.5831 of 5 stars$70.59-1.0%$111.23+57.6%+28.6%$3.89B$107.94M-23.6180News CoveragePositive NewsAnalyst ForecastACADACADIA Pharmaceuticals3.8654 of 5 stars$22.62-2.7%$28.13+24.3%+25.4%$3.79B$996.28M16.51510News CoverageUpcoming EarningsAnalyst RevisionVKTXViking Therapeutics3.8641 of 5 stars$33.20-3.5%$86.92+161.8%-38.4%$3.73BN/A-21.7020News CoverageShort Interest ↑ Related Companies and Tools Related Companies CYTK Alternatives ZLAB Alternatives ADMA Alternatives ABVX Alternatives RNA Alternatives MTSR Alternatives AKRO Alternatives ACLX Alternatives ACAD Alternatives VKTX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MENS) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jyong Biotech Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jyong Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MENS Stock Alerts